Mirum Pharmaceuticals, Inc.
MIRM
$44.73
-$0.54-1.19%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/14/2025
-
Insider Monkey
5/14/2025
-
Ticker Report
5/13/2025
-
GuruFocus
5/13/2025
-
GuruFocus
5/13/2025
-
The Fly
5/13/2025
-
MarketBeat
5/13/2025
-
MarketBeat
5/12/2025
-
GuruFocus
5/12/2025
-
ETF Channel
5/9/2025
-
GuruFocus
5/9/2025
-
GuruFocus
5/9/2025
-
Business Wire
5/9/2025
-
Simply Wall St
5/9/2025
-
GuruFocus
5/9/2025
-
Business Wire
5/9/2025
-
GuruFocus
5/9/2025
-
The Fly
5/9/2025
-
Tickeron - Stocks
5/9/2025
-
MarketBeat
5/8/2025
-
Zacks Investment Research
5/8/2025
-
GuruFocus
5/8/2025
-
GuruFocus
5/8/2025
-
GuruFocus
5/8/2025
-
SeekingAlpha
5/8/2025
-
Seeking Alpha: Transcripts
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 7, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 667 4085
Address
950 Tower Lane
Foster City, CA 94404
Foster City, CA 94404
Country
Year Founded
Business Description
Sector
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate...
more